Yahoo
NasdaqGM - Delayed Quote USD

BioHarvest Sciences Inc. (BHST)

1.8200 +0.0200 (+1.11%)
At close: September 4 at 4:00:01 PM EDT
1.7800 -0.0400 (-2.20%)
After hours: September 4 at 7:30:03 PM EDT
Chart Range Bar
Loading chart for BHST
  • Previous Close 1.8000
  • Open 1.8000
  • Bid 2.1400 x 100
  • Ask 2.2800 x 100
  • Day's Range 1.8000 - 1.8500
  • 52 Week Range 1.8000 - 12.8000
  • Volume 49,584
  • Avg. Volume 51,168
  • Market Cap (intraday) 41.255M
  • Beta (5Y Monthly) 1.35
  • PE Ratio (TTM) --
  • EPS (TTM) -0.5100
  • Earnings Date (est.) Nov 12, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 10.50

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional food and beverages, as well as the manufacturing, marketing, and sale of science-based health, pharmaceutical, and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company has a strategic collaboration with Tate & Lyle plc for the development of plant-based sweetener molecules. The company is based in Vancouver, Canada.

www.bioharvest.com

89

Full Time Employees

December 31

Fiscal Year Ends

Packaged Foods

Industry

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BHST
64.93%
S&P 500 (^GSPC)
12.75%

1-Year Return

BHST
76.08%
S&P 500 (^GSPC)
18.71%

3-Year Return

BHST
60.00%
S&P 500 (^GSPC)
70.93%

5-Year Return

BHST
83.75%
S&P 500 (^GSPC)
70.18%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 8.51M
Earnings -2.64M
Profit Margin -31.05%

Q3

FY25

Q4

FY25

Q1

FY26

-2M
0
2M
4M
6M
8M
-30.0%
-28.0%
-26.0%

Analyst Insights

View More

Analyst Price Targets

5.00
10.50 Average
1.8200 Current
15.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/12/2026
Analyst Maxim Group
Rating Action Maintains
Rating Buy
Price Action Lowers
Price Target 12 -> 5

Statistics

View More

Valuation Measures

Annual
As of 9/1/2026
  • Market Cap

    43.75M

  • Enterprise Value

    37.62M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.08

  • Price/Book (mrq)

    1.90

  • Enterprise Value/Revenue

    1.07

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -31.21%

  • Return on Assets (ttm)

    -11.02%

  • Return on Equity (ttm)

    -142.50%

  • Revenue (ttm)

    35.48M

  • Net Income Avi to Common (ttm)

    -11.07M

  • Diluted EPS (ttm)

    -0.5100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    16.22M

  • Total Debt/Equity (mrq)

    79.41%

  • Levered Free Cash Flow (ttm)

    -11.85M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

1.8200 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: